359 related articles for article (PubMed ID: 32914012)
21. Advances in the understanding of human soft tissue sarcomas: molecular biology and therapeutic strategies (Review).
Milas M; Yu D; Pollock RE
Oncol Rep; 1998; 5(5):1275-9. PubMed ID: 9683850
[TBL] [Abstract][Full Text] [Related]
22. From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision Medicine.
Rao SR; Somarelli JA; Altunel E; Selmic LE; Byrum M; Sheth MU; Cheng S; Ware KE; Kim SY; Prinz JA; Devos N; Corcoran DL; Moseley A; Soderblom E; Hsu SD; Eward WC
Front Oncol; 2020; 10():117. PubMed ID: 32117764
[TBL] [Abstract][Full Text] [Related]
23. Making progress in a rare disease: emerging therapeutics in soft tissue sarcomas.
Choe J; Riedel R
F1000Res; 2018; 7():. PubMed ID: 30450193
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy.
Du XH; Wei H; Zhang P; Yao WT; Cai QQ
Front Oncol; 2020; 10():564852. PubMed ID: 33072594
[TBL] [Abstract][Full Text] [Related]
25. Targeted therapy of soft tissue sarcomas.
Wardelmann E; Chemnitz JM; Wendtner CM
Onkologie; 2012; 35 Suppl 1():21-7. PubMed ID: 22286584
[TBL] [Abstract][Full Text] [Related]
26. Sarcoma treatment in the era of molecular medicine.
Grünewald TG; Alonso M; Avnet S; Banito A; Burdach S; Cidre-Aranaz F; Di Pompo G; Distel M; Dorado-Garcia H; Garcia-Castro J; González-González L; Grigoriadis AE; Kasan M; Koelsche C; Krumbholz M; Lecanda F; Lemma S; Longo DL; Madrigal-Esquivel C; Morales-Molina Á; Musa J; Ohmura S; Ory B; Pereira-Silva M; Perut F; Rodriguez R; Seeling C; Al Shaaili N; Shaabani S; Shiavone K; Sinha S; Tomazou EM; Trautmann M; Vela M; Versleijen-Jonkers YM; Visgauss J; Zalacain M; Schober SJ; Lissat A; English WR; Baldini N; Heymann D
EMBO Mol Med; 2020 Nov; 12(11):e11131. PubMed ID: 33047515
[TBL] [Abstract][Full Text] [Related]
27. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
[TBL] [Abstract][Full Text] [Related]
28. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
[TBL] [Abstract][Full Text] [Related]
29. Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience.
Tirrò E; Martorana F; Micale G; Inzerilli N; Carciotto R; Romano C; Longhitano C; Motta G; Lanzafame K; Stella S; Massimino M; Vitale SR; Salvatorelli L; Magro G; Manzella L; Vigneri P
Pathol Res Pract; 2022 Apr; 232():153820. PubMed ID: 35240549
[TBL] [Abstract][Full Text] [Related]
30. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
31. Drug Development in Soft Tissue Sarcomas: Novel Targets and Recent Early Phase Trial Results.
Achenbach E; Lai D; Sen S
J Immunother Precis Oncol; 2020 May; 3(2):83-89. PubMed ID: 36751523
[TBL] [Abstract][Full Text] [Related]
32. Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas.
Merry E; Thway K; Jones RL; Huang PH
NPJ Precis Oncol; 2021 Mar; 5(1):17. PubMed ID: 33674685
[TBL] [Abstract][Full Text] [Related]
33. TRK inhibition in soft tissue sarcomas: A comprehensive review.
Assi T; Rassy E; Nassereddine H; Farhat F; Karak FE; Kattan J; Ghosn M
Semin Oncol; 2020 Feb; 47(1):73-84. PubMed ID: 32201016
[TBL] [Abstract][Full Text] [Related]
34. Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?
van Oost S; Meijer DM; Kuijjer ML; Bovée JVMG; de Miranda NFCC
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440251
[TBL] [Abstract][Full Text] [Related]
35. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
[TBL] [Abstract][Full Text] [Related]
36. Exploring the landscape of immunotherapy approaches in sarcomas.
Pilavaki P; Panagi M; Arifi S; Jones RL; Stylianopoulos T; Constantinidou A
Front Oncol; 2022; 12():1069963. PubMed ID: 36686827
[TBL] [Abstract][Full Text] [Related]
37. Towards precision oncology in angiosarcomas using next generation "omic" technologies.
Tan GF; Chan JY
Oncotarget; 2021 Sep; 12(19):1953-1955. PubMed ID: 34548911
[TBL] [Abstract][Full Text] [Related]
38. Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II.
Martínez-Trufero J; Cruz Jurado J; Hernández-León CN; Correa R; Asencio JM; Bernabeu D; Alvarez R; Hindi N; Mata C; Marquina G; Martínez V; Redondo A; Floría LJ; Gómez-Mateo MC; Lavernia J; Sebio A; Garcia Del Muro X; Martin-Broto J; Valverde-Morales C
Cancer Treat Rev; 2021 Sep; 99():102260. PubMed ID: 34340159
[TBL] [Abstract][Full Text] [Related]
39. Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions.
Aranha O; Agulnik M
Expert Opin Ther Targets; 2008 Feb; 12(2):197-207. PubMed ID: 18208368
[TBL] [Abstract][Full Text] [Related]
40. New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.
Lim J; Poulin NM; Nielsen TO
Clin Cancer Res; 2015 Nov; 21(21):4753-9. PubMed ID: 26330427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
